Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma

Authors :: Nicole Unger-Manhart
Petra Zieglmayer
Patrick Lemell
Eva Prieschl-Grassauer
René Zieglmayer
Andreas Goessl
Source :: World Allergy Organization Journal, Vol 13, Iss 8, Pp 100261-(2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Pulmonary and Respiratory Medicine
Budesonide
lcsh:Immunologic diseases. Allergy
business.industry
medicine.medical_treatment
Immunology
medicine.disease
Rhinocort aqua
Nasal spray
Grass pollen
medicine
Immunology and Allergy
In patient
business
lcsh:RC581-607
medicine.drug
Early onset
Therapeutic equivalence
Asthma

Tools